SEC EDGAR published this disclosure on 2026-07-10. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001820365-26-000009
acquired disposedA
codeA
direct or indirectD
form4
is derivativefalse
issuer nameCue Biopharma, Inc.
labelGrant or award
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001820365-26-000009",
"acquired_disposed": "A",
"code": "A",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "Cue Biopharma, Inc.",
"label": "Grant or award",
"person_name": "Camardo Daniel A.",
"price": 0,
"role": "Director",
"security": "Common Stock",
"shares": 21800,
"shares_owned_after": 21800,
"source_path": "edgar/data/1820365/0001820365-26-000009.txt",
"ticker": "CUE",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.